Circ_0003575 knockdown alleviates ox-LDL-induced human aortic endothelial cell dysfunction in atherosclerosis by
Zhanshuai Zhang1, Shaoqiang Qin1, Rui Wang1
1Department of Cardiovascular Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei, China.
Background:
Circular RNAs (circRNAs) are involved in the progression of atherosclerosis (AS). The present study aimed to determine the functions and mechanism of circ_0003575 in AS.
Methods:
Oxidized low-density lipoprotein (ox-LDL) was used to induce human aortic endothelial cells (HAECs) to establish an AS cell model. Cell Counting Kit-8 (CCK-8) assay and 5'-ethynyl-2'-deoxyuridine (EdU) assay were conducted to assess cell proliferation. Flow cytometry analysis was utilized to quantify cell apoptosis. Tube formation assay was performed to analyze angiogenesis ability. Enzyme linked immunosorbent assay (ELISA) was used to examine the concentrations of inflammatory factors. Quantitative real-time polymerase chain reaction (qRT-PCR) and western blot were manipulated for the expression of circ_0003575, microRNA-637 (miR-637) and TNF receptor associated factor 6 (TRAF6). Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were adopted to estimate the downstream targets of circ_0003575.
Results:
Ox-LDL treatment repressed the proliferation and angiogenesis and promoted the apoptosis and inflammation in HAECs. Circ_0003575 knockdown ameliorated ox-LDL-induced injury of HAECs. Circ_0003575 interacted with mi-R-637, which directly targeted TRAF6. Inhibition of miR-637 reversed the impacts of circ_0003575 knockdown on HAEC injury. Moreover, miR-637 overexpression promoted cell proliferation and angiogenesis and inhibited cell apoptosis and inflammation by targeting TRAF6 in ox-LDL-treated HAECs. Further, circ_0003575 silencing inhibited the activation of NF-κB pathway.
Conclusion:
Circ_0003575 knockdown alleviated ox-LDL-induced HAEC damage by regulating miR-637/TRAF6 and NF-κB pathways.
Insights
Circular RNA circ_0003575 promotes atherosclerosis by damaging human aortic endothelial cells. Inhibiting circ_0003575 protects against this damage by regulating the miR-637/TRAF6 and NF-κB pathways.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- RNA Biology
Background:
- Circular RNAs (circRNAs) are implicated in atherosclerosis (AS) progression.
- The specific role of circ_0003575 in AS pathogenesis requires elucidation.
Purpose of the Study:
- To investigate the functional role and underlying mechanism of circ_0003575 in an in vitro model of atherosclerosis.
- To determine the interaction between circ_0003575, microRNA-637 (miR-637), and TNF receptor associated factor 6 (TRAF6) in endothelial cells.
Main Methods:
- Established an atherosclerosis cell model using oxidized low-density lipoprotein (ox-LDL) treated human aortic endothelial cells (HAECs).
- Assessed cell proliferation (CCK-8, EdU), apoptosis (flow cytometry), angiogenesis (tube formation assay), and inflammatory factor release (ELISA).
- Quantified gene and protein expression (qRT-PCR, Western blot) and investigated molecular interactions (dual-luciferase, RIP assays).
Main Results:
- Ox-LDL induced endothelial cell injury, characterized by reduced proliferation and angiogenesis, and increased apoptosis and inflammation.
- Knockdown of circ_0003575 significantly ameliorated ox-LDL-induced HAEC damage.
- Circ_0003575 directly targeted miR-637, which in turn targeted TRAF6. MiR-637 overexpression mimicked the protective effects of circ_0003575 knockdown.
- Circ_0003575 silencing inhibited the NF-κB signaling pathway activation.
Conclusions:
- Circ_0003575 knockdown exerts protective effects against ox-LDL-induced human aortic endothelial cell injury.
- The mechanism involves the regulation of the miR-637/TRAF6 axis and the NF-κB pathway.
- Circ_0003575 represents a potential therapeutic target for atherosclerosis.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Nitric Oxide Signaling Pathway


